Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ATAI - Biotech Rips In Anticipation Of Q3 Results

ATAI - Biotech Rips In Anticipation Of Q3 Results

ATAI Life Sciences N.V.

Certain events bring about volatility that creates massive opportunities for traders on either side of the screen. That’s exactly what happened on Tuesday after a Berlin-based %Biotech company announced it plans to announce its third quarter 2022 financial results and business update on Thursday, November 10, 2022.

Traders tried to get ahead of this event during Tuesday’s session as shares of %ATAILifeSciences () were pushed up to $3.65/share (+23.73%) at the early session high.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Stock Information
Company Name: ATAI Life Sciences N.V.
Stock Symbol: ATAI
Market: NASDAQ
Website: atai.life
Menu
ATAI ATAI Quote ATAI Short ATAI News ATAI Articles ATAI Message Board
Get ATAI Alerts

News, Short Squeeze, Breakout and More Instantly...